Acurx Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

ISSUANCE OF EQUITY INTERESTS - Fair Value (Details)	Jul. 25, 2022 USD ($) $ / shares Y	Jun. 29, 2021 USD ($) $ / shares Y
Underwriter
Warrants fair value
Fair value of Warrants		$ 618,000
Underwriter \| Measurement Input, Expected Term
Warrants fair value
Measurement Input, Warrants \| Y		4.5
Underwriter \| Measurement Input, Risk Free Rate
Warrants fair value
Measurement Input, Warrants		0.79
Underwriter \| Measurement Input, Share Price
Warrants fair value
Measurement Input, Warrants \| $ / shares		6.26
Underwriter \| Measurement Input, Volatility
Warrants fair value
Measurement Input, Warrants		94
Placement Agents
Warrants fair value
Fair value of Warrants	$ 171,409
Placement Agents \| Measurement Input, Expected Term
Warrants fair value
Measurement Input, Warrants \| Y	5
Placement Agents \| Measurement Input, Risk Free Rate
Warrants fair value
Measurement Input, Warrants	2.82
Placement Agents \| Measurement Input, Share Price
Warrants fair value
Measurement Input, Warrants \| $ / shares	3.70
Placement Agents \| Measurement Input, Volatility
Warrants fair value
Measurement Input, Warrants	95